Viridian Therapeutics
VRDN
#5015
Rank
NZ$3.01 B
Marketcap
NZ$27.34
Share price
-0.81%
Change (1 day)
26.42%
Change (1 year)

Market capitalization of Viridian Therapeutics (VRDN)

Market cap: NZ$3.01 Billion

As of May 2026 Viridian Therapeutics has a market cap of NZ$3.01 Billion. This makes Viridian Therapeutics the world's 5015th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Viridian Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$3.01 B-42.53%
2025NZ$5.25 B92.31%
2024NZ$2.73 B50.84%
2023NZ$1.81 B-2.19%
2022NZ$1.85 B167.41%
2021NZ$0.69 B617.85%
2020NZ$96.46 M288.32%
2019NZ$24.84 M-82.17%
2018NZ$0.13 B-57.48%
2017NZ$0.32 B6008.72%
2016NZ$5.36 M-53.86%
2015NZ$11.62 M-5.21%
2014NZ$12.26 M

End of Day market cap according to different sources

On May 19th, 2026 the market cap of Viridian Therapeutics was reported to be:

NZ$2.81 Billion
by Nasdaq info icon info icon
NZ$3.01 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$1.41 B-53.22%๐Ÿ‡บ๐Ÿ‡ธ USA